THOMAS SMITH
- Type
- Physician · Allopathic & Osteopathic Physicians / Psychiatry & Neurology / Neurology
- Where
- MECHANICSVILLE, VA
- NPI
- 1952372112
- Received
- $182,187 in 834 records, 2019 to 2025
- Source
- CMS Open Payments search ↗
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2025 | General payment | 55 | $30,096 |
| 2024 | General payment | 63 | $26,542 |
| 2023 | General payment | 121 | $21,512 |
| 2022 | General payment | 178 | $24,835 |
| 2021 | General payment | 152 | $22,812 |
| 2020 | General payment | 104 | $27,346 |
| 2019 | General payment | 161 | $29,040 |
By company
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a v | 98 | $155,235 |
| Food and Beverage | 653 | $15,087 |
| Consulting Fee | 4 | $5,905 |
| Travel and Lodging | 70 | $5,092 |
| Education | 9 | $866 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2025-12-18 | ABBVIE INC. | $2,000 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | QULIPTA Drug, NEUROSCIENCE | 2025 | |
| 2025-12-18 | Janssen Biotech, Inc. | $28 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-12-18 | Amgen Inc. | $21 | Food and Beverage | In-kind items and services | UPLIZNA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-12-18 | Celgene Corporation | $14 | Food and Beverage | Cash or cash equivalent | ZEPOSIA Drug, Neuroscience | 2025 | |
| 2025-12-10 | ABBVIE INC. | $107 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2025 | |
| 2025-12-10 | ABBVIE INC. | $24 | Travel and Lodging | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2025 | |
| 2025-11-19 | Lundbeck LLC | $119 | Food and Beverage | Cash or cash equivalent | VYEPTI Biological, NEUROLOGY | 2025 | |
| 2025-11-04 | Medtronic, Inc. | $21 | Food and Beverage | In-kind items and services | PERCEPT PC BRAINSENSE Device, Deep Brain Neurostimulation | 2025 | |
| 2025-10-23 | ABBVIE INC. | $2,000 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | QULIPTA Drug, NEUROSCIENCE | 2025 | |
| 2025-10-16 | ABBVIE INC. | $2,000 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | QULIPTA Drug, NEUROSCIENCE | 2025 | |
| 2025-10-10 | ABBVIE INC. | $42 | Travel and Lodging | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2025 | |
| 2025-10-10 | ABBVIE INC. | $16 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2025 | |
| 2025-10-03 | ABBVIE INC. | $26 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2025 | |
| 2025-10-03 | ABBVIE INC. | $21 | Travel and Lodging | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2025 | |
| 2025-10-02 | ABBVIE INC. | $900 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | QULIPTA Drug, NEUROSCIENCE | 2025 | |
| 2025-10-02 | Lilly USA, LLC | $124 | Food and Beverage | Cash or cash equivalent | KISUNLA Drug, Neuroscience | 2025 | |
| 2025-09-26 | ABBVIE INC. | $2,000 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | QULIPTA Drug, NEUROSCIENCE | 2025 | |
| 2025-09-26 | ABBVIE INC. | $21 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2025 | |
| 2025-09-26 | ABBVIE INC. | $11 | Travel and Lodging | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2025 | |
| 2025-09-18 | ABBVIE INC. | $2,000 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | QULIPTA Drug, NEUROSCIENCE | 2025 | |
| 2025-09-17 | Alexion Pharmaceuticals, Inc. | $134 | Food and Beverage | In-kind items and services | ULTOMIRIS Biological, Rare Disease | 2025 | |
| 2025-09-11 | ABBVIE INC. | $2,000 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | QULIPTA Drug, NEUROSCIENCE | 2025 | |
| 2025-09-10 | ABBVIE INC. | $19 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2025 | |
| 2025-09-05 | ABBVIE INC. | $28 | Travel and Lodging | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2025 | |
| 2025-09-05 | ABBVIE INC. | $23 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2025 | |
| 2025-08-25 | Bayer Healthcare Pharmaceuticals Inc. | $20 | Food and Beverage | In-kind items and services | Kerendia Drug, Cardio-Renal | 2025 | |
| 2025-08-20 | Celgene Corporation | $14 | Food and Beverage | Cash or cash equivalent | ZEPOSIA Drug, Neuroscience | 2025 | |
| 2025-08-13 | ABBVIE INC. | $121 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2025 | |
| 2025-08-04 | ABBVIE INC. | $2,000 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | QULIPTA Drug, NEUROSCIENCE | 2025 | |
| 2025-07-24 | ABBVIE INC. | $2,000 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | QULIPTA Drug, NEUROSCIENCE | 2025 | |
| 2025-07-18 | ABBVIE INC. | $27 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2025 | |
| 2025-07-11 | ABBVIE INC. | $26 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2025 | |
| 2025-07-11 | ABBVIE INC. | $21 | Travel and Lodging | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2025 | |
| 2025-07-10 | ABBVIE INC. | $2,000 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | QULIPTA Drug, NEUROSCIENCE | 2025 | |
| 2025-07-01 | ABBVIE INC. | $27 | Travel and Lodging | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2025 | |
| 2025-07-01 | ABBVIE INC. | $26 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2025 | |
| 2025-06-17 | E.R. Squibb & Sons, L.L.C. | $1,760 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPOSIA Drug, Neuroscience | 2025 | |
| 2025-06-13 | E.R. Squibb & Sons, L.L.C. | $70 | Travel and Lodging | Cash or cash equivalent | ZEPOSIA Drug, Neuroscience | 2025 | |
| 2025-05-28 | ABBVIE INC. | $2,000 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | UBRELVY Drug, NEUROSCIENCE | 2025 | |
| 2025-05-19 | ABBVIE INC. | $23 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2025 | |
| 2025-05-19 | ABBVIE INC. | $14 | Travel and Lodging | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2025 | |
| 2025-05-16 | ABBVIE INC. | $2,000 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | QULIPTA Drug, NEUROSCIENCE | 2025 | |
| 2025-05-15 | UCB, Inc. | $17 | Food and Beverage | In-kind items and services | Briviact Drug, Neurology | 2025 | |
| 2025-05-15 | Janssen Biotech, Inc. | $13 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-05-13 | E.R. Squibb & Sons, L.L.C. | $30 | Food and Beverage | Cash or cash equivalent | ZEPOSIA Drug, Neuroscience | 2025 | |
| 2025-04-28 | ABBVIE INC. | $21 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2025 | |
| 2025-04-28 | ABBVIE INC. | $18 | Travel and Lodging | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2025 | |
| 2025-04-18 | E.R. Squibb & Sons, L.L.C. | $1,760 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPOSIA Drug, Neuroscience | 2025 | |
| 2025-04-15 | E.R. Squibb & Sons, L.L.C. | $28 | Travel and Lodging | Cash or cash equivalent | ZEPOSIA Drug, Neuroscience | 2025 | |
| 2025-04-08 | Celgene Corporation | $13 | Food and Beverage | Cash or cash equivalent | ZEPOSIA Drug, Neuroscience | 2025 | |
| 2025-03-20 | E.R. Squibb & Sons, L.L.C. | $124 | Food and Beverage | Cash or cash equivalent | ZEPOSIA Drug, Neuroscience | 2025 | |
| 2025-03-18 | ABBVIE INC. | $2,000 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | UBRELVY Drug, NEUROSCIENCE | 2025 | |
| 2025-02-26 | ABBVIE INC. | $49 | Travel and Lodging | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2025 | |
| 2025-02-26 | ABBVIE INC. | $28 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2025 | |
| 2025-01-15 | E.R. Squibb & Sons, L.L.C. | $132 | Travel and Lodging | Cash or cash equivalent | ZEPOSIA Drug, Neuroscience | 2025 | |
| 2024-12-20 | Celgene Corporation | $2,400 | Consulting Fee | Cash or cash equivalent | ZEPOSIA Drug, Neuroscience | 2024 | |
| 2024-12-19 | LivaNova USA, Inc. | $45 | Food and Beverage | In-kind items and services | VNS THERAPY SENTIVA MODEL 1000 GENERATOR Device, Neurology | 2024 | |
| 2024-12-17 | Celgene Corporation | $8 | Food and Beverage | Cash or cash equivalent | ZEPOSIA Drug, Neuroscience | 2024 | |
| 2024-12-06 | ABBVIE INC. | $2,000 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | UBRELVY Drug, NEUROSCIENCE | 2024 | |
| 2024-12-06 | Celgene Corporation | $601 | Travel and Lodging | Cash or cash equivalent | ZEPOSIA Drug, Neuroscience | 2024 | |
| 2024-12-06 | Celgene Corporation | $212 | Travel and Lodging | Cash or cash equivalent | ZEPOSIA Drug, Neuroscience | 2024 | |
| 2024-12-06 | Celgene Corporation | $124 | Food and Beverage | Cash or cash equivalent | ZEPOSIA Drug, Neuroscience | 2024 | |
| 2024-12-06 | Celgene Corporation | $50 | Food and Beverage | Cash or cash equivalent | ZEPOSIA Drug, Neuroscience | 2024 | |
| 2024-12-06 | Celgene Corporation | $50 | Food and Beverage | Cash or cash equivalent | ZEPOSIA Drug, Neuroscience | 2024 | |
| 2024-12-06 | Celgene Corporation | $31 | Food and Beverage | Cash or cash equivalent | ZEPOSIA Drug, Neuroscience | 2024 | |
| 2024-12-06 | Celgene Corporation | $26 | Food and Beverage | Cash or cash equivalent | ZEPOSIA Drug, Neuroscience | 2024 | |
| 2024-12-06 | Celgene Corporation | $26 | Food and Beverage | Cash or cash equivalent | ZEPOSIA Drug, Neuroscience | 2024 | |
| 2024-11-20 | ABBVIE INC. | $53 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2024 | |
| 2024-11-20 | ABBVIE INC. | $20 | Travel and Lodging | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2024 | |
| 2024-11-04 | ABBVIE INC. | $2,000 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | QULIPTA Drug, NEUROSCIENCE | 2024 | |
| 2024-11-04 | ABBVIE INC. | $2,000 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | QULIPTA Drug, NEUROSCIENCE | 2024 | |
| 2024-10-09 | Alexion Pharmaceuticals, Inc. | $100 | Education | In-kind items and services | ULTOMIRIS Biological, Rare Disease | 2024 | |
| 2024-10-09 | Alexion Pharmaceuticals, Inc. | $100 | Education | In-kind items and services | ULTOMIRIS Biological, Rare Disease | 2024 | |
| 2024-10-08 | Lilly USA, LLC | $121 | Food and Beverage | Cash or cash equivalent | KISUNLA Drug, Neuroscience | 2024 | |
| 2024-09-30 | PFIZER INC. | $15 | Food and Beverage | In-kind items and services | ZAVZPRET Drug, PAIN | 2024 | |
| 2024-09-26 | Celgene Corporation | $13 | Food and Beverage | Cash or cash equivalent | ZEPOSIA Drug, Neuroscience | 2024 | |
| 2024-09-20 | E.R. Squibb & Sons, L.L.C. | $1,478 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPOSIA Drug, Neuroscience | 2024 | |
| 2024-09-18 | Lundbeck LLC | $81 | Food and Beverage | Cash or cash equivalent | VYEPTI Biological, NEUROLOGY | 2024 | |
| 2024-09-18 | Lundbeck LLC | $28 | Food and Beverage | Cash or cash equivalent | VYEPTI Biological, NEUROLOGY | 2024 | |
| 2024-09-17 | ABBVIE INC. | $20 | Travel and Lodging | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2024 | |
| 2024-09-17 | ABBVIE INC. | $15 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2024 | |
| 2024-09-16 | ABBVIE INC. | $22 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2024 | |
| 2024-09-16 | ABBVIE INC. | $20 | Travel and Lodging | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2024 | |
| 2024-08-27 | E.R. Squibb & Sons, L.L.C. | $32 | Food and Beverage | Cash or cash equivalent | ZEPOSIA Drug, Neuroscience | 2024 | |
| 2024-08-02 | ABBVIE INC. | $2,000 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | UBRELVY Drug, NEUROSCIENCE | 2024 | |
| 2024-07-17 | Alexion Pharmaceuticals, Inc. | $122 | Food and Beverage | In-kind items and services | ULTOMIRIS Biological, Rare Disease | 2024 | |
| 2024-07-17 | ABBVIE INC. | $29 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2024 | |
| 2024-07-17 | ABBVIE INC. | $16 | Travel and Lodging | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2024 | |
| 2024-07-12 | LivaNova USA, Inc. | $45 | Food and Beverage | In-kind items and services | VNS THERAPY SENTIVA MODEL 1000 GENERATOR Device, Neurology | 2024 | |
| 2024-06-18 | PFIZER INC. | $23 | Food and Beverage | In-kind items and services | NURTEC ODT Drug, PAIN | 2024 | |
| 2024-06-11 | Celgene Corporation | $8 | Food and Beverage | Cash or cash equivalent | ZEPOSIA Drug, Neuroscience | 2024 | |
| 2024-05-17 | ABBVIE INC. | $2,000 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | QULIPTA Drug, NEUROSCIENCE | 2024 | |
| 2024-05-15 | Alexion Pharmaceuticals, Inc. | $100 | Education | In-kind items and services | ULTOMIRIS Biological, Rare Disease | 2024 | |
| 2024-05-15 | Alexion Pharmaceuticals, Inc. | $100 | Education | In-kind items and services | ULTOMIRIS Biological, Rare Disease | 2024 | |
| 2024-05-15 | Neurelis, Inc. | $97 | Food and Beverage | In-kind items and services | VALTOCO Drug, EPILEPSY | 2024 | |
| 2024-05-06 | E.R. Squibb & Sons, L.L.C. | $1,773 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPOSIA Drug, Neuroscience | 2024 | |
| 2024-05-06 | E.R. Squibb & Sons, L.L.C. | $1,478 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPOSIA Drug, Neuroscience | 2024 | |
| 2024-04-25 | ABBVIE INC. | $31 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2024 | |
| 2024-04-25 | ABBVIE INC. | $20 | Travel and Lodging | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2024 | |
| 2024-04-24 | E.R. Squibb & Sons, L.L.C. | $28 | Food and Beverage | Cash or cash equivalent | ZEPOSIA Drug, Neuroscience | 2024 | |
| 2024-04-19 | UCB, Inc. | $27 | Food and Beverage | In-kind items and services | Briviact Drug, Neurology | 2024 | |
| 2024-04-18 | E.R. Squibb & Sons, L.L.C. | $27 | Food and Beverage | Cash or cash equivalent | ZEPOSIA Drug, Neuroscience | 2024 | |
| 2024-04-12 | ABBVIE INC. | $2,000 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | UBRELVY Drug, NEUROSCIENCE | 2024 | |
| 2024-04-10 | Celgene Corporation | $8 | Food and Beverage | Cash or cash equivalent | ZEPOSIA Drug, Neuroscience | 2024 | |
| 2024-03-28 | ABBVIE INC. | $46 | Travel and Lodging | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2024 | |
| 2024-03-28 | ABBVIE INC. | $17 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2024 | |
| 2024-03-20 | SK Life Science, Inc. | $123 | Food and Beverage | In-kind items and services | XCOPRI Drug, Neurology | 2024 | |
| 2024-03-11 | Celgene Corporation | $300 | Consulting Fee | Cash or cash equivalent | ZEPOSIA Drug, Neuroscience | 2024 | |
| 2024-02-21 | Eisai Inc. | $121 | Food and Beverage | Cash or cash equivalent | Leqembi Drug, Neurology | 2024 | |
| 2024-02-07 | Celgene Corporation | $7 | Food and Beverage | Cash or cash equivalent | ZEPOSIA Drug, Neuroscience | 2024 | |
| 2024-02-02 | ABBVIE INC. | $2,000 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | UBRELVY Drug, NEUROSCIENCE | 2024 | |
| 2024-01-26 | ABBVIE INC. | $2,000 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | QULIPTA Drug, NEUROSCIENCE | 2024 | |
| 2024-01-17 | TG Therapeutics, Inc. | $85 | Food and Beverage | In-kind items and services | BRIUMVI Drug, Immunology | 2024 | |
| 2024-01-17 | ABBVIE INC. | $28 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2024 | |
| 2024-01-17 | ABBVIE INC. | $24 | Travel and Lodging | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2024 | |
| 2024-01-17 | SK Life Science, Inc. | $13 | Food and Beverage | In-kind items and services | 2024 | ||
| 2024-01-16 | ABBVIE INC. | $108 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2024 | |
| 2024-01-16 | ABBVIE INC. | $26 | Travel and Lodging | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2024 | |
| 2023-11-30 | Celgene Corporation | $5 | Food and Beverage | Cash or cash equivalent | ZEPOSIA Drug, Neuroscience | 2023 | |
| 2023-11-15 | KYOWA KIRIN, INC. | $133 | Food and Beverage | In-kind items and services | Nourianz Drug, Adenosine A2A Receptors | 2023 | |
| 2023-11-10 | ABBVIE INC. | $2,000 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | QULIPTA Drug, NEUROSCIENCE | 2023 | |
| 2023-11-01 | ABBVIE INC. | $32 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2023 | |
| 2023-11-01 | ABBVIE INC. | $19 | Travel and Lodging | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2023 | |
| 2023-09-20 | ANI Pharmaceuticals, Inc. | $116 | Food and Beverage | In-kind items and services | PURIFIED CORTROPHIN GEL Drug, Treatment of certain chronic autoimmune disorders, including acute exacerbations of MS and RA | 2023 | |
| 2023-08-29 | Celgene Corporation | $9 | Food and Beverage | Cash or cash equivalent | ZEPOSIA Drug, Neuroscience | 2023 | |
| 2023-08-26 | PFIZER INC. | $12 | Food and Beverage | In-kind items and services | NURTEC ODT Drug, PAIN | 2023 | |
| 2023-08-24 | Celgene Corporation | $17 | Food and Beverage | Cash or cash equivalent | ZEPOSIA Drug, Neuroscience | 2023 | |
| 2023-08-24 | ABBVIE INC. | $6 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2023 | |
| 2023-08-23 | CATALYST PHARMACEUTICALS, INC. | $20 | Food and Beverage | Cash or cash equivalent | FYCOMPA Drug, NEUROLOGY | 2023 | |
| 2023-08-22 | Otsuka America Pharmaceutical, Inc. | $17 | Food and Beverage | In-kind items and services | NUEDEXTA Drug, NEUROLOGY | 2023 | |
| 2023-08-21 | Neurelis, Inc. | $15 | Food and Beverage | In-kind items and services | VALTOCO Drug, EPILEPSY | 2023 | |
| 2023-08-16 | ABBVIE INC. | $16 | Food and Beverage | In-kind items and services | DUOPA Drug, NEUROSCIENCE | 2023 | |
| 2023-08-15 | ABBVIE INC. | $1 | Food and Beverage | In-kind items and services | BOTOX Biological, NEUROSCIENCE | 2023 | |
| 2023-08-11 | ABBVIE INC. | $2,000 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | QULIPTA Drug, NEUROSCIENCE | 2023 | |
| 2023-08-09 | Averitas Pharma Inc. | $14 | Food and Beverage | In-kind items and services | QUTENZA Drug, PAIN MANAGEMENT | 2023 | |
| 2023-08-07 | SK Life Science, Inc. | $27 | Food and Beverage | In-kind items and services | 2023 | ||
| 2023-08-03 | ABBVIE INC. | $2,000 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | UBRELVY Drug, NEUROSCIENCE | 2023 | |
| 2023-08-03 | ANI Pharmaceuticals, Inc. | $29 | Food and Beverage | In-kind items and services | PURIFIED CORTROPHIN GEL Drug, Treatment of certain chronic autoimmune disorders, including acute exacerbations of MS and RA | 2023 | |
| 2023-07-31 | Celgene Corporation | $14 | Food and Beverage | Cash or cash equivalent | ZEPOSIA Drug, Neuroscience | 2023 | |
| 2023-07-28 | Teva Pharmaceuticals USA, Inc. | $13 | Food and Beverage | In-kind items and services | Austedo XR Drug, Central Nervous System | 2023 | |
| 2023-07-27 | ABBVIE INC. | $117 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2023 | |
| 2023-07-27 | UCB, Inc. | $33 | Food and Beverage | In-kind items and services | Briviact Drug, Neurology | 2023 | |
| 2023-07-27 | ABBVIE INC. | $19 | Travel and Lodging | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2023 | |
| 2023-07-27 | Celgene Corporation | $3 | Food and Beverage | Cash or cash equivalent | ZEPOSIA Drug, Neuroscience | 2023 | |
| 2023-07-26 | ABBVIE INC. | $30 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2023 | |
| 2023-07-26 | Alexion Pharmaceuticals, Inc. | $27 | Food and Beverage | In-kind items and services | ULTOMIRIS Biological, Rare Disease | 2023 | |
| 2023-07-26 | ABBVIE INC. | $26 | Travel and Lodging | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2023 | |
| 2023-07-26 | ABBVIE INC. | $6 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2023 | |
| 2023-07-24 | KYOWA KIRIN, INC. | $18 | Food and Beverage | In-kind items and services | Nourianz Drug, Adenosine A2A Receptors | 2023 | |
| 2023-07-24 | KYOWA KIRIN, INC. | $0 | Food and Beverage | In-kind items and services | Nourianz Drug, Adenosine A2A Receptors | 2023 | |
| 2023-07-20 | Genentech USA, Inc. | $23 | Food and Beverage | In-kind items and services | Enspryng Biological, Immunology | 2023 | |
| 2023-07-20 | ABBVIE INC. | $7 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2023 | |
| 2023-07-18 | Celgene Corporation | $10 | Food and Beverage | Cash or cash equivalent | ZEPOSIA Drug, Neuroscience | 2023 | |
| 2023-07-17 | Biogen, Inc. | $20 | Food and Beverage | In-kind items and services | TYSABRI Biological, Neurology | 2023 | |
| 2023-07-17 | ABBVIE INC. | $1 | Food and Beverage | In-kind items and services | BOTOX Biological, NEUROSCIENCE | 2023 | |
| 2023-07-14 | Grifols USA, LLC | $16 | Food and Beverage | In-kind items and services | Gamunex-C Biological, Immunology and Neurology | 2023 | |
| 2023-07-11 | ABBVIE INC. | $14 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-07-09 | JAZZ PHARMACEUTICALS INC. | $25 | Food and Beverage | In-kind items and services | EPIDIOLEX Drug, NEUROLOGY | 2023 | |
| 2023-07-05 | UCB, Inc. | $30 | Food and Beverage | In-kind items and services | Briviact Drug, Neurology | 2023 | |
| 2023-07-05 | Celgene Corporation | $1 | Food and Beverage | Cash or cash equivalent | ZEPOSIA Drug, Neuroscience | 2023 | |
| 2023-06-29 | ABBVIE INC. | $2,000 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | QULIPTA Drug, NEUROSCIENCE | 2023 | |
| 2023-06-22 | PFIZER INC. | $20 | Food and Beverage | In-kind items and services | COMIRNATY Biological, VACCINES | 2023 | |
| 2023-06-21 | Alexion Pharmaceuticals, Inc. | $21 | Food and Beverage | In-kind items and services | ULTOMIRIS Biological, Rare Disease | 2023 | |
| 2023-06-15 | ABBVIE INC. | $2,000 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | QULIPTA Drug, NEUROSCIENCE | 2023 | |
| 2023-06-14 | ABBVIE INC. | $27 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2023 | |
| 2023-06-13 | ABBVIE INC. | $19 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2023 | |
| 2023-06-13 | ABBVIE INC. | $2 | Food and Beverage | In-kind items and services | BOTOX Biological, NEUROSCIENCE | 2023 | |
| 2023-06-08 | ABBVIE INC. | $2,000 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | QULIPTA Drug, NEUROSCIENCE | 2023 | |
| 2023-06-06 | ABBVIE INC. | $300 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | QULIPTA Drug, NEUROSCIENCE | 2023 | |
| 2023-06-06 | ABBVIE INC. | $25 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2023 | |
| 2023-06-06 | Celgene Corporation | $9 | Food and Beverage | Cash or cash equivalent | ZEPOSIA Drug, Neuroscience | 2023 | |
| 2023-06-06 | Celgene Corporation | $0 | Food and Beverage | Cash or cash equivalent | ZEPOSIA Drug, Neuroscience | 2023 | |
| 2023-06-01 | EMD Serono, Inc. | $15 | Food and Beverage | Cash or cash equivalent | MAVENCLAD Drug, Neurology | 2023 | |
| 2023-05-31 | Genentech USA, Inc. | $20 | Food and Beverage | In-kind items and services | Enspryng Biological, Immunology | 2023 | |
| 2023-05-23 | KYOWA KIRIN, INC. | $6 | Food and Beverage | In-kind items and services | Nourianz Drug, Adenosine A2A Receptors | 2023 | |
| 2023-05-23 | KYOWA KIRIN, INC. | $2 | Food and Beverage | In-kind items and services | Nourianz Drug, Adenosine A2A Receptors | 2023 | |
| 2023-05-19 | ABBVIE INC. | $32 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2023 | |
| 2023-05-19 | ABBVIE INC. | $19 | Travel and Lodging | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2023 | |
| 2023-05-19 | ABBVIE INC. | $9 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-05-16 | ANI Pharmaceuticals, Inc. | $19 | Food and Beverage | In-kind items and services | PURIFIED CORTROPHIN GEL Drug, Treatment of certain chronic autoimmune disorders, including acute exacerbations of MS and RA | 2023 | |
| 2023-05-16 | Celgene Corporation | $4 | Food and Beverage | Cash or cash equivalent | ZEPOSIA Drug, Neuroscience | 2023 | |
| 2023-05-16 | Celgene Corporation | $3 | Food and Beverage | Cash or cash equivalent | ZEPOSIA Drug, Neuroscience | 2023 | |
| 2023-05-15 | SK Life Science, Inc. | $26 | Food and Beverage | In-kind items and services | 2023 | ||
| 2023-05-12 | Teva Pharmaceuticals USA, Inc. | $85 | Education | In-kind items and services | 2023 | ||
| 2023-05-12 | Teva Pharmaceuticals USA, Inc. | $64 | Education | In-kind items and services | 2023 | ||
| 2023-05-04 | ABBVIE INC. | $2,000 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | QULIPTA Drug, NEUROSCIENCE | 2023 | |
| 2023-05-04 | Alexion Pharmaceuticals, Inc. | $21 | Food and Beverage | In-kind items and services | ULTOMIRIS Biological, Rare Disease | 2023 | |
| 2023-05-04 | Novartis Pharmaceuticals Corporation | $20 | Food and Beverage | In-kind items and services | MAYZENT Drug, Neurology | 2023 | |
| 2023-05-01 | ABBVIE INC. | $16 | Food and Beverage | In-kind items and services | BOTOX Biological, NEUROSCIENCE | 2023 | |
| 2023-04-27 | ABBVIE INC. | $34 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2023 | |
| 2023-04-20 | Alexion Pharmaceuticals, Inc. | $20 | Food and Beverage | In-kind items and services | ULTOMIRIS Biological, Rare Disease | 2023 | |
| 2023-04-18 | ABBVIE INC. | $15 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2023 | |
| 2023-04-13 | Celgene Corporation | $2 | Food and Beverage | Cash or cash equivalent | ZEPOSIA Drug, Neuroscience | 2023 | |
| 2023-04-12 | Lilly USA, LLC | $19 | Food and Beverage | In-kind items and services | EMGALITY Drug, Neuroscience | 2023 | |
| 2023-04-12 | IMPEL PHARMACEUTICALS INC. | $18 | Food and Beverage | Cash or cash equivalent | Trudhesa Drug, Neurology | 2023 | |
| 2023-04-11 | Mallinckrodt Hospital Products Inc. | $26 | Food and Beverage | In-kind items and services | ACTHAR Biological, IMMUNOLOGY | 2023 | |
| 2023-04-11 | UCB, Inc. | $15 | Food and Beverage | In-kind items and services | Briviact Drug, Neurology | 2023 | |
| 2023-04-10 | KYOWA KIRIN, INC. | $12 | Food and Beverage | In-kind items and services | Nourianz Drug, Adenosine A2A Receptors | 2023 | |
| 2023-04-06 | ABBVIE INC. | $300 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | QULIPTA Drug, NEUROSCIENCE | 2023 | |
| 2023-04-05 | TG Therapeutics, Inc. | $21 | Food and Beverage | In-kind items and services | BRIUMVI Drug, Immunology | 2023 |
The latest 200 records of 834.
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Mechanicsville, VA, county Hanover County, VA, state Virginia; placed by its city name.
| Measure | Place (city or town) Mechanicsville, VA | County Hanover County, VA | State Virginia |
|---|---|---|---|
| Population B01003 | 38,683 | 112,879 | 8,705,170 |
| Population, 2020 census P1 | 39,482 | 109,979 | 8,631,393 |
| Median age B01002 | 41.8 | 42.7 | 39.0 |
| Under 18 B01001 | 21.8% | 21.6% | 21.7% |
| 65 and over B01001 | 19.8% | 19.2% | 16.7% |
| Households B11001 | 15,337 | 42,688 | 3,365,732 |
| Foreign born B05002 | 3.8% | 4.3% | 13.1% |
| Median household income B19013 | $98,595 | $112,805 | $93,170 |
| Median family income B19113 | $120,441 | $132,791 | $115,213 |
| Per capita income B19301 | $45,231 | $53,490 | $50,666 |
| Poverty rate B17001 | 5.2% | 5.7% | 9.9% |
| Unemployment rate B23025 | 1.9% | 2.7% | 4.3% |
| Civilian labor force B23025 | 20,438 | 60,013 | 4,468,236 |
| Mean commute (minutes) B08013 | 23.9 | 26.9 | 27.3 |
| Bachelor's degree or higher B15003 | 35.8% | 42.7% | 42.2% |
| Housing units B25001 | 15,947 | 44,589 | 3,684,756 |
| Owner-occupied B25003 | 75.5% | 82.1% | 67.3% |
| Renters B25003 | 24.5% | 17.9% | 32.7% |
| Median home value B25077 | $351,000 | $400,400 | $383,700 |
| Median gross rent B25064 | $1,724 | $1,591 | $1,579 |
| White, not Hispanic B03002 | 82.3% | 80.7% | 58.4% |
| Black B03002 | 8.2% | 8.3% | 18.3% |
| Hispanic or Latino B03002 | 2.8% | 4.0% | 11.0% |
| Asian B03002 | 1.5% | 2.1% | 6.9% |
| American Indian and Alaska Native B03002 | 0.0% | 0.1% | 0.1% |
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Mechanicsville, VA.
Comments